These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

621 related items for PubMed ID: 15990678

  • 21. [Comparative study of HMB-45 monoclonal antibody uptake on various benign and malignant melanocytic lesions].
    Lampert A, Thomine E, Lauret P, Hemet J.
    Ann Pathol; 1993; 13(2):100-7. PubMed ID: 8363667
    [Abstract] [Full Text] [Related]

  • 22. Cdc7 expression in melanomas, Spitz tumors and melanocytic nevi.
    Clarke LE, Fountaine TJ, Hennessy J, Bruggeman RD, Clarke JT, Mauger DT, Helm KF.
    J Cutan Pathol; 2009 Apr; 36(4):433-8. PubMed ID: 19278428
    [Abstract] [Full Text] [Related]

  • 23. Different expression patterns of p27 and p57 proteins in benign and malignant melanocytic neoplasms and in cultured human melanocytes.
    Curry JL, Richards HW, Huttenbach YT, Medrano EE, Reed JA.
    J Cutan Pathol; 2009 Feb; 36(2):197-205. PubMed ID: 18647205
    [Abstract] [Full Text] [Related]

  • 24. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
    Khalifeh I, Taraif S, Reed JA, Lazar AF, Diwan AH, Prieto VG.
    Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281
    [Abstract] [Full Text] [Related]

  • 25. Expression of vascular endothelial growth factor in early cutaneous melanocytic lesion progression.
    Einspahr JG, Thomas TL, Saboda K, Nickolof BJ, Warneke J, Curiel-Lewandrowski C, Ranger-Moore J, Duckett L, Bangert J, Fruehauf JP, Alberts DS.
    Cancer; 2007 Dec 01; 110(11):2519-27. PubMed ID: 17932890
    [Abstract] [Full Text] [Related]

  • 26. Prognostic significance of nuclear ING3 expression in human cutaneous melanoma.
    Wang Y, Dai DL, Martinka M, Li G.
    Clin Cancer Res; 2007 Jul 15; 13(14):4111-6. PubMed ID: 17634537
    [Abstract] [Full Text] [Related]

  • 27. Nestin expression in cutaneous melanomas and melanocytic nevi.
    Brychtova S, Fiuraskova M, Hlobilková A, Brychta T, Hirnak J.
    J Cutan Pathol; 2007 May 15; 34(5):370-5. PubMed ID: 17448190
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Immunohistochemical expression patterns of the microRNA-processing enzyme Dicer in cutaneous malignant melanomas, benign melanocytic nevi and dysplastic melanocytic nevi.
    Sand M, Gambichler T, Sand D, Altmeyer P, Stuecker M, Bechara FG.
    Eur J Dermatol; 2011 May 15; 21(1):18-21. PubMed ID: 21262599
    [Abstract] [Full Text] [Related]

  • 30. Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions.
    Natali PG, Hamby CV, Felding-Habermann B, Liang B, Nicotra MR, Di Filippo F, Giannarelli D, Temponi M, Ferrone S.
    Cancer Res; 1997 Apr 15; 57(8):1554-60. PubMed ID: 9108459
    [Abstract] [Full Text] [Related]

  • 31. Cytoplasmic beta-catenin is lacking in a subset of melanoma-associated naevi, but is detectable in naevus-associated melanomas: potential implications for melanoma tumorigenesis?
    De Panfilis G, Ferrari D, Santoro S, Ricci R, Lombardi M, Pedrazzi G, Pepe C, Cortelazzi C, Santini M.
    Br J Dermatol; 2009 Mar 15; 160(3):600-8. PubMed ID: 19183173
    [Abstract] [Full Text] [Related]

  • 32. Expression of c-kit (CD117) in Spitz nevus and malignant melanoma.
    Isabel Zhu Y, Fitzpatrick JE.
    J Cutan Pathol; 2006 Jan 15; 33(1):33-7. PubMed ID: 16441409
    [Abstract] [Full Text] [Related]

  • 33. Differential expression of microtubule-associated protein 2 in melanocytic skin lesions.
    Gambichler T, Rotterdam S, Radkowski K, Altmeyer P, Kreuter A.
    Am J Clin Pathol; 2009 May 15; 131(5):710-4. PubMed ID: 19369632
    [Abstract] [Full Text] [Related]

  • 34. Diagnostic and prognostic role of galectin 3 expression in cutaneous melanoma.
    Abdou AG, Hammam MA, Farargy SE, Farag AG, El Shafey EN, Farouk S, Elnaidany NF.
    Am J Dermatopathol; 2010 Dec 15; 32(8):809-14. PubMed ID: 20885286
    [Abstract] [Full Text] [Related]

  • 35. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
    Shin J, Vincent JG, Cuda JD, Xu H, Kang S, Kim J, Taube JM.
    J Am Acad Dermatol; 2012 Oct 15; 67(4):717-26. PubMed ID: 22325460
    [Abstract] [Full Text] [Related]

  • 36. Different expression of lysosome-associated membrane protein-1 in human melanomas and benign melanocytic lesions.
    Kuźbicki L, Gajo B, Chwirot BW.
    Melanoma Res; 2006 Jun 15; 16(3):235-43. PubMed ID: 16718270
    [Abstract] [Full Text] [Related]

  • 37. Loss of EphB6 expression in metastatic melanoma.
    Hafner C, Bataille F, Meyer S, Becker B, Roesch A, Landthaler M, Vogt T.
    Int J Oncol; 2003 Dec 15; 23(6):1553-9. PubMed ID: 14612926
    [Abstract] [Full Text] [Related]

  • 38. Fascin, cortactin and survivin expression of melanocytic neoplasms and association with clinicopathological parameters and anatomic locations in Chinese people.
    Gao HW, Yu CP, Lee HS, Nieh S, Chiang CP, Wang WM, Jin JS.
    Eur J Dermatol; 2010 Dec 15; 20(3):293-301. PubMed ID: 20400386
    [Abstract] [Full Text] [Related]

  • 39. Malignant melanoma with neuroendocrine differentiation: clinical, histological, immunohistochemical and ultrastructural features of three cases.
    Eyden B, Pandit D, Banerjee SS.
    Histopathology; 2005 Oct 15; 47(4):402-9. PubMed ID: 16178895
    [Abstract] [Full Text] [Related]

  • 40. Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma.
    Massi D, Naldini A, Ardinghi C, Carraro F, Franchi A, Paglierani M, Tarantini F, Ketabchi S, Cirino G, Hollenberg MD, Geppetti P, Santucci M.
    Hum Pathol; 2005 Jun 15; 36(6):676-85. PubMed ID: 16021575
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.